DK0817769T3 - Nye borneolestere, fremgangsmåder til deres fremstilling og deres farmaceutiske anvendelse - Google Patents
Nye borneolestere, fremgangsmåder til deres fremstilling og deres farmaceutiske anvendelseInfo
- Publication number
- DK0817769T3 DK0817769T3 DK96909153T DK96909153T DK0817769T3 DK 0817769 T3 DK0817769 T3 DK 0817769T3 DK 96909153 T DK96909153 T DK 96909153T DK 96909153 T DK96909153 T DK 96909153T DK 0817769 T3 DK0817769 T3 DK 0817769T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- farnesyl
- oesters
- preparation
- methods
- Prior art date
Links
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 title 1
- 229910052796 boron Inorganic materials 0.000 title 1
- 150000001637 borneol derivatives Chemical class 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 101100212791 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YBL068W-A gene Proteins 0.000 abstract 1
- 102000004243 Tubulin Human genes 0.000 abstract 1
- 108090000704 Tubulin Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 230000000986 microtubule polymerisation Effects 0.000 abstract 1
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 abstract 1
- 239000003909 protein kinase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19513040A DE19513040A1 (de) | 1995-03-29 | 1995-03-29 | Neue Borneolester, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| PCT/EP1996/001404 WO1996032376A1 (de) | 1995-03-29 | 1996-03-29 | Neue borneolester, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0817769T3 true DK0817769T3 (da) | 1999-11-08 |
Family
ID=7759027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96909153T DK0817769T3 (da) | 1995-03-29 | 1996-03-29 | Nye borneolestere, fremgangsmåder til deres fremstilling og deres farmaceutiske anvendelse |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5965609A (da) |
| EP (1) | EP0817769B1 (da) |
| JP (1) | JPH11503171A (da) |
| AT (1) | ATE180469T1 (da) |
| CA (1) | CA2216655A1 (da) |
| DE (2) | DE19513040A1 (da) |
| DK (1) | DK0817769T3 (da) |
| ES (1) | ES2133953T3 (da) |
| GR (1) | GR3030870T3 (da) |
| WO (1) | WO1996032376A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2212237A1 (en) * | 1997-09-05 | 1999-03-05 | John M. Webster | Novel antineoplastic agents |
| EP3308783B1 (en) | 2015-06-10 | 2021-03-03 | Jiangsu Simcere Pharmaceutical Co., Ltd | Edaravone and borneol for treating amyotrophic lateral sclerosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601676B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Procede de preparation du taxol et du desacetyl-10 taxol |
| US5248796A (en) * | 1992-06-18 | 1993-09-28 | Bristol-Myers Squibb Company | Taxol derivatives |
| DE4416374A1 (de) * | 1994-05-05 | 1995-11-09 | Schering Ag | Neue Borneolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
-
1995
- 1995-03-29 DE DE19513040A patent/DE19513040A1/de not_active Withdrawn
-
1996
- 1996-03-29 AT AT96909153T patent/ATE180469T1/de not_active IP Right Cessation
- 1996-03-29 DK DK96909153T patent/DK0817769T3/da active
- 1996-03-29 US US08/930,009 patent/US5965609A/en not_active Expired - Fee Related
- 1996-03-29 WO PCT/EP1996/001404 patent/WO1996032376A1/de not_active Ceased
- 1996-03-29 JP JP8530683A patent/JPH11503171A/ja not_active Ceased
- 1996-03-29 CA CA002216655A patent/CA2216655A1/en not_active Abandoned
- 1996-03-29 DE DE59602007T patent/DE59602007D1/de not_active Expired - Lifetime
- 1996-03-29 ES ES96909153T patent/ES2133953T3/es not_active Expired - Lifetime
- 1996-03-29 EP EP96909153A patent/EP0817769B1/de not_active Expired - Lifetime
-
1999
- 1999-07-27 GR GR990401956T patent/GR3030870T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0817769B1 (de) | 1999-05-26 |
| ATE180469T1 (de) | 1999-06-15 |
| CA2216655A1 (en) | 1996-10-17 |
| GR3030870T3 (en) | 1999-11-30 |
| JPH11503171A (ja) | 1999-03-23 |
| DE59602007D1 (de) | 1999-07-01 |
| US5965609A (en) | 1999-10-12 |
| WO1996032376A1 (de) | 1996-10-17 |
| ES2133953T3 (es) | 1999-09-16 |
| EP0817769A1 (de) | 1998-01-14 |
| DE19513040A1 (de) | 1996-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guse | Ca 2+ signaling in T-lymphocytes | |
| ATE234857T1 (de) | Antithrombotische tripeptid-wirkstoffe | |
| NO20005715L (no) | Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| DE69030315D1 (de) | Kleine zyklische inhibitoren der blutplättchenaggregation | |
| FR2804115B1 (fr) | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant | |
| SE8107634L (sv) | Nya tri-, tetra- och pentapeptider, forfaranden for framstellning av desamma och lekemedel innehallande desamma | |
| Klein et al. | IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23 | |
| ATE191908T1 (de) | Neue verbindungen | |
| DK0817769T3 (da) | Nye borneolestere, fremgangsmåder til deres fremstilling og deres farmaceutiske anvendelse | |
| AR005233A1 (es) | Derivados de 1,2,3,4-tetrahidroquinolina, procesos para su preparacion, una composicion farmaceutica y el uso en la elaboracion de un medicamento | |
| Peyron et al. | Phosphorylation of two cytosolic proteins. An early event of T-cell activation | |
| DK0553113T3 (da) | Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismer | |
| FR2707089B1 (fr) | Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| Blazquez et al. | Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface Tat-binding proteins | |
| Krueger | Somnogenic activity of muramyl peptides | |
| Roark et al. | Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme | |
| Oostendorp et al. | Suppression of lymphocyte proliferation by a retroviral p15E‐derived hexapeptide | |
| Ramirez et al. | HLA class-II-mediated homotypic aggregation: involvement of a protein tyrosine kinase and protein kinase C | |
| MX9707610A (es) | Derivados de fenoxietilamina que tienen una afinidad elevada hacia el receptor 5-ht1a, su procedimiento de preparacion, su aplicacion como medicamento y las composiciones farmaceuticas que los contienen. | |
| Lafont et al. | Evidence for a CD4‐associated calcium influx independent of the phosphoinositide transduction pathway in human T cells | |
| FR2751652B1 (fr) | Derives du thienylcyclohexane, des procedes pour leur preparation et leur utilisation en tant que produits industriels nouveaux pour la synthese de derives thienylcyclohexyles | |
| Pharmingen | Purified Mouse anti-NF-κB p65 (pS529) | |
| Markham | Natural killer cell-mediated cytotoxicity and the multidrug resistance (MDR1) gene product, P-glycoprotein |